LETM1
Basic information
Region (hg38): 4:1811479-1856156
Links
Phenotypes
GenCC
Source:
- neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction (Moderate), mode of inheritance: AR
- neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction (Strong), mode of inheritance: AR
- neurodevelopmental disorder (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Childhood-onset neurodegeneration with multisystem involvement due to mitochondrial dysfunction | AR | Audiologic/Otolaryngologic; Cardiovascular | Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; The condition can involve early-onset cardiomyopathy, and awareness may allow early management | Audiologic/Otolaryngologic; Biochemical; Cardiovascular; Craniofacial; Endocrine; Musculoskeletal; Neurologic; Ophthalmologic | 36055214 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LETM1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 73 | 82 | ||||
missense | 101 | 11 | 119 | |||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 9 | 5 | 1 | 15 | ||
non coding | 25 | 30 | ||||
Total | 0 | 2 | 108 | 104 | 23 |
Variants in LETM1
This is a list of pathogenic ClinVar variants found in the LETM1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-1814424-C-G | LETM1-associated clinical spectrum with predominant nervous system involvement • Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction • Global developmental delay | Uncertain significance (Aug 01, 2021) | ||
4-1814441-C-T | Uncertain significance (Nov 01, 2022) | |||
4-1814442-G-A | Likely benign (Nov 27, 2024) | |||
4-1814442-G-T | Likely benign (Jul 21, 2022) | |||
4-1814481-C-T | Likely benign (May 15, 2023) | |||
4-1814505-T-C | Likely benign (Aug 17, 2023) | |||
4-1814517-C-T | Likely benign (Jan 05, 2018) | |||
4-1814527-T-C | Uncertain significance (Sep 27, 2022) | |||
4-1814530-C-T | Inborn genetic diseases | Uncertain significance (Feb 27, 2023) | ||
4-1814549-CT-C | LETM1-associated clinical spectrum with predominant nervous system involvement • Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction | Pathogenic (Oct 25, 2022) | ||
4-1814554-T-C | Benign (Dec 19, 2023) | |||
4-1814576-A-G | Uncertain significance (Dec 26, 2020) | |||
4-1814582-G-C | LETM1-associated clinical spectrum with predominant nervous system involvement • Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction | Pathogenic (Oct 26, 2022) | ||
4-1814588-A-G | Likely benign (Aug 10, 2022) | |||
4-1815655-G-A | Benign (Jan 22, 2024) | |||
4-1815669-C-T | Uncertain significance (Nov 07, 2022) | |||
4-1815705-C-T | Uncertain significance (Feb 24, 2024) | |||
4-1815739-T-G | Benign (Jan 23, 2024) | |||
4-1815742-G-A | Likely benign (Sep 27, 2022) | |||
4-1815747-T-C | Uncertain significance (Jun 03, 2024) | |||
4-1815760-C-T | Likely benign (Aug 19, 2022) | |||
4-1815768-C-T | Inborn genetic diseases | Uncertain significance (Jan 08, 2024) | ||
4-1815772-G-T | Likely benign (Aug 01, 2024) | |||
4-1815778-C-T | Likely benign (Nov 05, 2024) | |||
4-1815783-C-G | Inborn genetic diseases | Uncertain significance (Sep 29, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LETM1 | protein_coding | protein_coding | ENST00000302787 | 14 | 44769 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000121 | 0.998 | 125682 | 0 | 66 | 125748 | 0.000262 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.58 | 341 | 433 | 0.787 | 0.0000281 | 4786 |
Missense in Polyphen | 88 | 145.98 | 0.60282 | 1558 | ||
Synonymous | -1.65 | 219 | 190 | 1.15 | 0.0000131 | 1492 |
Loss of Function | 2.70 | 15 | 31.3 | 0.480 | 0.00000143 | 397 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000566 | 0.000564 |
Ashkenazi Jewish | 0.00139 | 0.00139 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000203 | 0.000202 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000294 | 0.000294 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Mitochondrial proton/calcium antiporter that mediates proton-dependent calcium efflux from mitochondrion (PubMed:19797662). Crucial for the maintenance of mitochondrial tubular networks and for the assembly of the supercomplexes of the respiratory chain (PubMed:18628306). Required for the maintenance of the tubular shape and cristae organization (PubMed:18628306). In contrast to SLC8B1/NCLX, does not constitute the major factor for mitochondrial calcium extrusion (PubMed:24898248). {ECO:0000269|PubMed:18628306, ECO:0000269|PubMed:19797662, ECO:0000269|PubMed:24898248}.;
- Pathway
- Transport of small molecules;Mitochondrial calcium ion transport
(Consensus)
Recessive Scores
- pRec
- 0.0964
Intolerance Scores
- loftool
- 0.0849
- rvis_EVS
- 0.54
- rvis_percentile_EVS
- 81.09
Haploinsufficiency Scores
- pHI
- 0.106
- hipred
- Y
- hipred_score
- 0.639
- ghis
- 0.449
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.990
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Letm1
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; embryo phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype;
Gene ontology
- Biological process
- mitochondrial calcium ion transmembrane transport;protein hexamerization;cristae formation;protein homooligomerization;mitochondrial calcium ion homeostasis;calcium export from the mitochondrion
- Cellular component
- mitochondrion;mitochondrial inner membrane;integral component of membrane
- Molecular function
- calcium ion binding;protein binding;calcium:proton antiporter activity;ribosome binding